1 Nausea |
8 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
1.1 PC6 acupoint stimulation and droperidol |
2 |
128 |
Risk Ratio (IV, Random, 95% CI) |
0.77 [0.15, 4.10] |
1.2 PC6 acupoint stimulation and ondansetron |
4 |
295 |
Risk Ratio (IV, Random, 95% CI) |
0.79 [0.47, 1.33] |
1.3 PC6 acupoint stimulation, dexamethasone and ondansetron |
2 |
219 |
Risk Ratio (IV, Random, 95% CI) |
0.69 [0.50, 0.93] |
1.4 All PC6 acupoint stimulation and antiemetic combinations |
8 |
642 |
Risk Ratio (IV, Random, 95% CI) |
0.79 [0.55, 1.13] |
1.5 Invasive PC6 stimulation |
2 |
120 |
Risk Ratio (IV, Random, 95% CI) |
0.28 [0.11, 0.75] |
1.6 Noninvasive PC6 stimulation |
6 |
522 |
Risk Ratio (IV, Random, 95% CI) |
0.88 [0.62, 1.25] |
1.7 Low risk of bias trials |
1 |
119 |
Risk Ratio (IV, Random, 95% CI) |
0.58 [0.38, 0.88] |
1.8 Unclear risk of bias trials |
4 |
355 |
Risk Ratio (IV, Random, 95% CI) |
0.86 [0.61, 1.20] |
1.9 High risk of bias trials |
3 |
168 |
Risk Ratio (IV, Random, 95% CI) |
0.58 [0.12, 2.66] |
1.10 Trials with control event rate less than or equal to 20% |
1 |
40 |
Risk Ratio (IV, Random, 95% CI) |
0.14 [0.01, 2.60] |
1.11 Trials with control event rate more than 20% |
7 |
602 |
Risk Ratio (IV, Random, 95% CI) |
0.81 [0.56, 1.16] |
2 Vomiting |
9 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
2.1 PC6 acupoint stimulation and droperidol |
3 |
173 |
Risk Ratio (IV, Random, 95% CI) |
0.62 [0.19, 1.99] |
2.2 PC6 acupoint stimulation and ondansetron |
4 |
295 |
Risk Ratio (IV, Random, 95% CI) |
0.51 [0.20, 1.30] |
2.3 PC6 acupoint stimulation and dexamethasone and ondansetron |
2 |
219 |
Risk Ratio (IV, Random, 95% CI) |
0.49 [0.30, 0.79] |
2.4 All PC6 acupoint stimulation and antiemetic combinations |
9 |
687 |
Risk Ratio (IV, Random, 95% CI) |
0.56 [0.35, 0.91] |
2.5 Children |
1 |
60 |
Risk Ratio (IV, Random, 95% CI) |
0.83 [0.43, 1.63] |
2.6 Adult |
8 |
627 |
Risk Ratio (IV, Random, 95% CI) |
0.51 [0.29, 0.91] |
2.7 Invasive PC6 stimulation |
3 |
180 |
Risk Ratio (IV, Random, 95% CI) |
0.34 [0.08, 1.40] |
2.8 Noninvasive PC6 stimulation |
6 |
507 |
Risk Ratio (IV, Random, 95% CI) |
0.65 [0.38, 1.11] |
2.9 Low risk of bias trials |
1 |
119 |
Risk Ratio (IV, Random, 95% CI) |
0.53 [0.30, 0.94] |
2.10 Unclear risk of bias trials |
4 |
355 |
Risk Ratio (IV, Random, 95% CI) |
0.52 [0.25, 1.09] |
2.11 High risk of bias trials |
4 |
213 |
Risk Ratio (IV, Random, 95% CI) |
0.56 [0.19, 1.64] |
2.12 Trials with control event rate less than or equal to 20% |
2 |
120 |
Risk Ratio (IV, Random, 95% CI) |
0.13 [0.02, 1.04] |
2.13 Trials with control event rate more than 20% |
7 |
567 |
Risk Ratio (IV, Random, 95% CI) |
0.61 [0.37, 1.00] |
3 Rescue antiemetic |
5 |
419 |
Risk Ratio (IV, Random, 95% CI) |
0.61 [0.44, 0.86] |